education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Taxilan
Taxilan
sucralfate
Manufacturer:
Pharos
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Sucralfate
Indications/Uses
Short-term treatment (up to 8 wk) of duodenal ulcer.
Dosage/Direction for Use
Adult
10 mL 4 times daily. Continue treatment unless there is demonstrated healing by endoscopy or x-ray.
Administration
Should be taken on an empty stomach: Take 1 hr before meals & before bedtime.
Special Precautions
Chronic kidney failure & patients under dialysis. Administer antacids in ½ hr interval before or after sucralfate. Pregnancy & lactation. Childn.
Adverse Reactions
Constipation, dry mouth.
View
ADR Reporting Link
Drug Interactions
Reduce absorption or bioavailability of cimetidine, ciprofloxacin, digoxin, ketoconazole, norfloxacin, phenytoin, ranitidine, tetracycline & theophylline.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02BX02 - sucralfate ; Belongs to the class of other drugs used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Regulatory Classification
K
Presentation/Packing
Form
Taxilan oral susp 500 mg/5 mL
Packing/Price
180 mL x 1's (Rp63,000/botol)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk